Development of High Dose Oseltamivir Phosphate Dry Powder for Inhalation Therapy in Viral Pneumonia
Oseltamivir phosphate (OP) is an antiviral drug available only as oral therapy for the treatment of influenza and as a potential treatment option when in combination with other medication in the fight against the corona virus disease (COVID-19) pneumonia. In this study, OP was formulated as a dry po...
Saved in:
Main Authors: | Shahir Aziz (Author), Regina Scherlieβ (Author), Hartwig Steckel (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation
by: Imco Sibum, et al.
Published: (2019) -
Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler
by: Yoen-Ju Son, et al.
Published: (2021) -
Delivery of theophylline as dry powder for inhalation
by: Bing Zhu, et al.
Published: (2015) -
Feasibility of a High-Dose Inhaled Indomethacin Dry Powder with Dual Deposition for Pulmonary and Oral Delivery
by: Jamie E. Spahn, et al.
Published: (2024) -
The effect of inspiratory parameters after two separate inhalations on the dose emission of theophylline from low and high resistance dry powder inhalers
by: Mohamad Abadelah, et al.
Published: (2020)